Efficacy of artesunate in the treatment of urinary schistosomiasis, in an endemic community in Nigeria

References

• Borrmann, S., Szezale, N., Faucher, J. F., Matsiegui, P. B., Neubauer, R., Binder, R. K., Lell, B. & Kremsner, P. G. (2001). Artesunate and praziquantel for the treatment of Schistosoma haematobium infections; a double blind randomized placebo controlled study. Journal of Infectious Diseases, 184, 1363–1366.
   Google Scholar
• Chen, M. G. & Mott, K. E. (1989). Progress in the assessment of morbidity due to schistosomiasis. Tropical Diseases Bulletin, 86, 1–56.
   Google Scholar
• Chugh, K. S., Harries, A. D., Dahniya, M. H., Nwosu, A. C., Gashau, A., Thomas, J. O., Thaliza, T. D., Hogger, S., Ajewski, Z. & Onwuchekwa, A. C. (1986). Urinary schistosomiasis in Maiduguri, north east Nigeria. Annals of Tropical Medicine and Parasitology, 80,593–599.
   PubMed Web of Science ®Google Scholar
• De Clercq, D., Vercruysse, J., Kongs, A., Verb, P., Dompnier, J. P. & Faye, P. C. (2002). Efficacy of artesunate and praziquantel in Schistosoma haematobium infected school children. Acta Tropica, 82,61–66
   PubMed Web of Science ®Google Scholar
• Doenhoff, M. J., Kusel, J. R., Coles, G. C. & Coli, D. (2002). Resistance of Schistosoma mansoni to praziquantel. Is there a problem? Transactions of the Royal Society of Tropical Medicine and Hygiene, 96, 465–469.
   PubMed Web of Science ®Google Scholar
• Ejezie, G. C., Uko, I. E. & Braide, E. I. (1991). Schisto-somiasis in Cross River state, Nigeria. I. Prevalence and intensity of infection in Adim-Akamkpa local government area. Journal of Hygiene, Epidemiology, Microbiology, and Immunology, 35,141–147.
   PubMedGoogle Scholar
• Ejezie, G. C., Udoh, A. E., Meremikwu, M. M., Odigwe, C. O. & Useh, M. F. (1998). Some effects of annual treatment and re-treatment on morbidity indicators of urinary schistosomiasis. Mary Slessor Journal of Medicine, 1, 67–72.
   Google Scholar
• Fallon, P. G. & Doenhoff, M. J. (1994). Drug resistant schistosomiasis: resistance in praziquantel and oxamniquine induced in Schistosoma mansoni is drug specific. American Journal of Tropical Medicine and Hygiene, 51,83–88.
   PubMed Web of Science ®Google Scholar
• Fenwick, A., Salvioli, L., Engels, D., Bergquist, N. R. & Todd, M. H. (2003). Drugs for the control of parasitic diseases: current status and development in schistosomiasis. Trends in Parasitology, 19,514–520.
   Web of Science ®Google Scholar
• Guissé, F., Polman, K., Stelma, F. F., Mbaye, A., Talla, I., Niang, M., Deelder, A. M., Ndir, O. & Gryseels, B. (1997). Therapeutic evaluation of two different dose regimens of praziquantel in a recent Schistosoma mansoni focus in northern Senegal. American Journal of Tropical Medicine and Hygiene, 56,511–514.
   PubMed Web of Science ®Google Scholar
• Ismail, M., Botros, S., Metwally, A., William, S., Farghally, A., Tao, L.-F., Day, T. A. & Bennett, J. L. (1999). Resistance to praziquantel: direct evidence from Schistosoma mansoni isolated from Egyptian villagers. American Journal of Tropical Medicine and Hygiene, 60,932–935.
   PubMed Web of Science ®Google Scholar
• N'Goran, E. K., Utzinger, J., Gnaka, H. N., Yapi, A., N'Guessan, N. A., Kigbafori, S. D., Lengeler, C., Chollet, J., Xiao, S. H. & Tanner, M. (2003). Randomized, double-blind, placebo-controlled trial of oral artemether for the prevention of patent Schisto-soma haematobium infections. American Journal of Tropical Medicine and Hygiene, 68,24–32.
   PubMed Web of Science ®Google Scholar
• Stelma, F. F., Talla, A., Sow, S., Kongs, A., Niang, M., Polman, K., Deelder, A. M. & Gryseels, B. (1995). Efficacy and side effects of praziquantel in an epidemic focus of Schistosoma mansoni. American Journal of Tropical Medicine and Hygiene, 53,167–170.
   PubMed Web of Science ®Google Scholar
• Useh, M. F. & Ejezie, G. C. (1999a). Modification of behaviour and attitude in the control of schistoso-miasis. 1. Observations on water-contact patterns and perception of infection. Annals of Tropical Medicine and Parasitology, 93,711–720.
   PubMed Web of Science ®Google Scholar
• Useh, M. F. & Ejezie, G. C. (1999b). School-based schistosomiasis control programmes. A comparative study on the prevalence and intensity of urinary schistosomiasis among Nigerian school age children in and out of school. Transactions of the Royal Society of Tropical Medicine and Hygiene, 93,387–391.
   PubMed Web of Science ®Google Scholar
• Utzinger, J., N'Goran, E. K., N'Dri, A., Lengeler, C., Xiao, S. H. & Tanner, M. (2000). Oral artemether for prevention of Schistosoma mansoni infection: randomised controlled trial. Lancet, 355,1320–1325.
   PubMed Web of Science ®Google Scholar
• Utzinger, J., Xiao, S. H., Keiser, J., Chen, M. G., Zheng, J. & Tanner, M. (2001a). Current progress in the development and use of artemether for chem °prophylaxis of major human schistosome parasites. Current Medicinal Chemistry, 8,1841–1860.
   PubMed Web of Science ®Google Scholar
• Utzinger, J., Xiao, S. H., N'Goran, E. K., Bergquist, R. & Tanner, M. (2001 b). The potential of artemether for the control of schistosomiasis. International Journal for Parasitology, 31,1549–1562.
   PubMed Web of Science ®Google Scholar
• Utzinger, J., Keiser, J., Xiao, S. H., Tanner, M. & Singer, B. H. (2003). Combination chemotherapy of schistosomiasis in laboratory studies and clinical trials. Antimicrobial Agents and Chemotherapy, 47, 1487–1495.
   PubMed Web of Science ®Google Scholar
• White, N. J. (1999). Antimalarial drug resistance and combination therapy. Philosophical Transactions of the Royal Society of London, Series B, 354,739–749.
   PubMed Web of Science ®Google Scholar
• Winstanley, P. A. (2000). Chemotherapy for falciparum malaria. The armoury, the problems and the prospects. Parasitology Today, 16,146–153.
   PubMedGoogle Scholar
• World Health Organization (1990a). The Control of Schistosomiasis. Second Report of the WHO Expert Committee. Technical Report Series No. 830. Geneva: WHO.
   Google Scholar
• World Health Organization (1990 b). Health Education in the Control of Schistosomiasis. Geneva: WHO.
   Google Scholar
• World Health Organization (2002). Prevention and Control of Schistosomiasis and Soil Transmitted Helmin-thiasis: Report of a WHO Expert Committee. Technical Report Series No. 912. Geneva: WHO.
   Google Scholar
• Xiao, S. H. & Catto, B. A. (1989). In vivo and in vitro studies of the effect of artemether on Schistosoma mansoni. Antimicrobial Agents and Chemotherapy, 33, 1557–1562.
   PubMed Web of Science ®Google Scholar
• Xiao, S. H, You, J. Q., Yang, Y. Q. & Wang, C. Z. (1995). Experimental studies on early treatment of schistosomal infection with artemether. Southeast Asian Journal of Tropical Medicine and Public Health, 26, 306–318.
   PubMedGoogle Scholar
• Xiao, S. H., You, J. Y., Jiao, P. Y., Guo, H. F. & Geng, A. (1998). Preventive effect of artemether in rabbits infected with Schistosoma japonicum cercariae. Acta Pharmacologica Sinica, 19, 63–66.
   Web of Science ®Google Scholar
• Xiao, S. H., Booth, M. & Tanner, M. (2000a). The prophylactic effects of artemether against Schistosoma japonicum infections. Parasitology Today, 16, 146–153.
   PubMedGoogle Scholar
• Xiao, S. H., Chollet, J., Weiss, N. A., Bergquist, R. N. & Tanner, M. (2000b). Preventive effect of artemether in experimental animals infected with Schistosoma mansoni. Parasitology International, 49, 19–24.
   PubMed Web of Science ®Google Scholar
• Xiao, S. H., Utzinger, J., Chollet, J., N'Goran, E. K. & Tanner, M. (2000c). Effect of artemether against Schistosoma haematobium in experimentally infected hamsters. International Journal for Parasitology, 30, 1001–1006.
   Google Scholar
• Xiao, S. H., Chollet, J., Utzinger, J., Matile, H., Mei, J. Y. & Tanner, M. (2001). Artemether administered together with haemin damages schistosomes in vitro. Transactions of the Royal Society of Tropical Medicine and Hygiene, 95, 67–71.
   PubMed Web of Science ®Google Scholar